Daratumumab: A first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

Larysa Sanchez, Yucai Wang, David S. Siegel, Michael L. Wang

Research output: Contribution to journalReview articlepeer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Daratumumab: A first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences